Development and evaluation of ST-1829 based on 5-benzylidene-2-phenylthiazolones as promising agent for anti-leukotriene therapy. [electronic resource]
- European journal of medicinal chemistry Jan 2015
- 503-23 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't